Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells

Biochemical Pharmacology

Volumn 82, Issue 4, 2011, Pages 380-388

  Cantarella, Giuseppina ^a   Scollo, Mimmo ^a   Lempereur, Laurence ^a   Saccani Jotti, Gloria ^b   Basile, Francesco ^a   Bernardini, Renato ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Antagonist; Endocannabinoids; NGF related inflammation; Receptor

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CHEMOKINE RECEPTOR; ENDOCANNABINOID; GPR55 PROTEIN; NERVE GROWTH FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MAST CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

CELL LINE, TUMOR; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; HUMANS; INFLAMMATION; MAST CELLS; NERVE GROWTH FACTOR; RECEPTORS, G-PROTEIN-COUPLED; TETRADECANOYLPHORBOL ACETATE;

EID: 79960349725     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.05.004     Document Type: Article

References (43)

1. H. Thoenen The changing scene of the neurotrophic factors Trends Neurosci 14 1991 165 170
2. H. Jiang, V. Movsesyan, D.W. Fink Jr., M. Fasler, M. Whalin, and Y. Katagiri Expression of human p140trk receptors in p140trk-deficient, PC12/endhotelial cells resulting nerve growth factor-induced signa (Pubitemid 27287432)
3. R. Tabakman, S. Lecht, S. Sephanova, H. Arien-Zakay, and P. Lazarovici Interactions between the cells of the immune and nervous system:neurotrophins as neuroprotection mediators in CNS injury Progr Brain Res 146 2004 387 401 (Pubitemid 37541395)
4. N.O. Glebova, and D.D. Ginty Heterogeneous requirement of NGF for sympathetic target innervation in vivo J Neurosci 24 2004 743 751 (Pubitemid 38166500)
5. R. Levi-Montalcini The nerve growth factor 35 years later Science 37 1987 1154 1162 (Pubitemid 17124912)
6. M. Tuveri, S. Generini, M. Matucci-Cerinic, and L. Aloe NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis Lancet 356 2000 1739 1740
7. S.K. Raychaudhuri, S.P. Raychaudhuri, H. Weltman, and E.M. Farber Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells Arch Dermatol Res 293 2001 291 295 (Pubitemid 32661496)
8. G. Cantarella, L. Lempereur, M. Presta, D. Ribatti, G. Lombardo, and P. Lazarovici Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo FASEB J 16 2002 1307 1309
9. E. Crivellato, L. Travan, and D. Ribatti Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation Int Arch Allergy Immunol 151 2010 89 97
10. G. Nilsson, K. Forsberg-Nilsson, Z. Xiang, F. Hallböök, K. Nilsson, and D.D. Metcalfe Human mast cells express functional TrkA and area source of nerve growth factor Eur J Immunol 27 1997 2295 2301 (Pubitemid 27404313)
11. M.J. Nadler, S.A. Matthews, H. Turner, and J.P. Kinet Signal transduction by the high-affinity immunoglobulin E receptor FceRI: coupling form to function Adv Immunol 76 2000 325 355 (Pubitemid 33717331)
12. S. Maltby, K. Khazaie, and K.M. McNagny Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation Biochim Biophys Acta 1796 2009 19 26
13. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 32
14. N. Ferrara, K. Houck, L. Jakeman, and D.W. Leung Molecular and biological properties of the vascular endothelial growthfactor family of proteins Endocr Rev 13 1992 18 32
15. D. Ribatti Endogenous inhibitors of angiogenesis: a historical review Leuk Res 33 2009 638 644
16. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, and W.S. Lane Endostatin: anendogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285 (Pubitemid 28015876)
17. M. Bifulco, C. Laezza, P. Gazzerro, and F. Pentimalli Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion Oncol Rep 17 2007 813 816
18. V. Di Marzo Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7 2008 438 455 (Pubitemid 351649182)
19. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
20. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65 (Pubitemid 23305569)
21. L. De Petrocellis, V. Vellani, A. Schiano-Moriello, P. Marini, P.C. Magherini, and P. Orlando Plant-derived cannabinoids modulate theactivity of transient receptor potential channels of ankyrin type-1and melastatin type-8 J Pharmacol Exp Ther 325 2008 1007 1015 (Pubitemid 351724325)
22. E. Ryberg, N. Larsson, S. Sjögren, S. Hjorth, N.O. Hermansson, and J. Leonova The orphan receptor GPR55 is a novel cannabinoid receptor Br J Pharmacol 152 2007 1092 1101 (Pubitemid 350166046)
23. S. Mazzari, R. Canella, L. Petrelli, G. Marcolongo, and A. Leon N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation Eur J Pharmacol 300 1996 227 236
24. J.H. Butterfield, D.A. Weiler, L.W. Hunt, S.R. Wynn, and P.C. Roche Purification of tryptase from a human mast cell line J Leukoc Biol 47 1990 409 419 (Pubitemid 20155874)
25. E.A. Jaffe, R.L. Nachman, C.G. Becker, and C.R. Minick Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria J Clin Invest 52 1973 2745 2756
26. M.A. Gribaldeston, M. Metz, M. Yu, M. Tsai, and S.J. Galli Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses Curr Opin Immunol 18 2006 751 760 (Pubitemid 44642318)
27. L. Aloe, L. Bracci-Laudiero, S. Bonini, and L. Manni The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases Allergy 52 1997 883 994
28. D.D. Metcalfe, D. Baram, and Y.A. Mekori Mast cells Physiol Rev 77 1997 1033 1079 (Pubitemid 27459579)
29. N. Dmitrieva, and S.B. McMahon Sensitisation of visceral afferents by nerve growth factor in the adult rat Pain 66 1996 87 97 (Pubitemid 26247028)
30. W.P. Farquhar-Smith, and A.S. Rice A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia Anesthesiology 99 2003 1391 1401 (Pubitemid 37475187)
31. C.M. Williams, and S.J. Galli The diverse potential effector and immunoregulatory roles of mast cells in allergic disease J Allergy Clin Immunol 105 2000 847 859 (Pubitemid 30324391)
32. Q. Li, S.M. Whitcup, Y. Fujino, R.B. Nussenblatt, and C.C. Chan The role of mast cells in endotoxin-induced uveitis Invest Ophthalmol Vis Sci 34 1993 256 259 (Pubitemid 23045123)
33. B. Costa, S. Conti, G. Giagnoni, and M. Colleoni Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems Br J Pharmacol 137 2002 413 420 (Pubitemid 35221894)
34. M. Di Rosa, J.P. Giroud, and D.A. Willoughby Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine J Pathol 104 1971 15 29
35. M. Chen, B.K. Lam, Y. Kanaoka, P.A. Nigrovic, L.P. Audoly, and K.F. Austen Neutrophil-derived leukotriene B4 is required for inflammatory arthritis J Exp Med 203 2006 837 842
36. C. Badid, N. Mounier, A.M. Costa, and A. Desmoulire Role of myofibroblasts during normal tissue repair and excessive scarring: interest of their assessment in nephropathies Histol Histopathol 15 2000 269 280 (Pubitemid 30044310)
37. C. Emanueli, M.B. Salis, A. Pinna, G. Graiani, L. Manni, and P. Madeddu Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hind limbs Circulation 106 2002 2257 2262 (Pubitemid 35222222)
38. D.M. Lambert, S. Vandevoorde, K.O. Jonsson, and C.J. Fowler The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr Med Chem 9 2002 663 674 (Pubitemid 34296196)
39. D.J. Rog Cannabis-based medicines in multiple sclerosis: a review of clinical studies Immunobiology 215 2010 658 672
40. A.A. Izzo, and M. Camilleri Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects Gut 57 2008 1140 1155
41. D. Bolognini, B. Costa, S. Maione, F. Comelli, P. Marini, and V. Di Marzo The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice Br J Pharmacol 160 2010 677 687
42. M. Maccarrone, L. Fiorucci, F. Erba, M. Bari, A. Finazzi-Agr, and F. Ascoli Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors FEBS Lett 468 2000 176 180 (Pubitemid 30110791)
43. M. Pietr, E. Kozela, R. Levy, N. Rimmerman, Y.H. Lin, and N. Stella Differential changes in GPR55 during microglial cell activation FEBS Lett 583 2009 2071 2076